Dockets: 2006P-0242: Approval of any Budesonide Inhalation Suspension Product using Pulmicort Respules

U.S. Food and Drug Administration

horizonal rule

Dockets Management

2006P-0242: Approval of any Budesonide Inhalation Suspension Product using Pulmicort Respules

		Document #			Received Date							Filed Date			Submitter Code					Submitter				FR Date		FR Page						Comment Date						Files			Remarks


		CP1			06/09/2006							06/09/2006			Drug Industry					AstraZeneca LP (AstraZeneca)																			Table of Contents
																				Signature:		Alan R. Bennett

		ACK1			06/09/2006							06/09/2006			Federal Government					FDA/DDM to AstraZeneca LP																			pdf
																				Signature:		Gloria Ortega

		EC1			07/05/2006							07/03/2006			Individual Consumer					Mr. David Lowe																			htm

		EC2			07/10/2006							07/09/2006			Individual Consumer					Mr. Dave Lowe																			htm Attachment

		C1			09/12/2006							09/02/2006			Individual Consumer					D. Lowe

		LET1			12/07/2006							12/07/2006			Federal Government					FDA/CDER to Ropes & Gray																			pdf
																				Signature:		Jane A. Axelrad

Page last updated January 22, 2007 kk horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management